Skip to content

A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of fermented milk containing Lactobacillus gasseri SBT2055 (LG2055) on fecal fat excretion

A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of fermented milk containing Lactobacillus gasseri SBT2055 (LG2055) on fecal fat excretion - A clinical trial to investigate the effect of Lactobacillus gasseri SBT2055 (LG2055) on fecal fat excretion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015772
Enrollment
30
Registered
2014-11-29
Start date
2014-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Interventions

Fermented milk containing LG2055 100g/day for 7 days Fermented milk without LG2055 100g/day for 7 days

Sponsors

New drug research center, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy males and females over the age of 20 years

Exclusion criteria

Exclusion criteria: 1) Subjects who have frequency of defecation less than 5 days a week 2) Subjects who regularly ingest fermented milk 3) Subject with a history of allergy to medicine and food 4) Subjects who have severe internal organ disorders including coronary heart disease, respiratory impairment, endocrinopathy, or defective metabolism 5) Subjects who have a history of major surgery of digestive system 6) Subjects who consume special health-promoting foods, took medication known to alter lipid metabolism 7)Subject who is judged to be ineligible due to subject's background, physical findings, medical examination, physical and clinical examination by principal investigator or sub investigator

Design outcomes

Primary

MeasureTime frame
Amount of fecal fat before and after 7-day intake of fermented milk (Wet weight of feces, Total fecal fat level, Concentration of fecal fat)

Secondary

MeasureTime frame
Microbiota of feces before and after 7-day intake of fermented milk

Countries

Japan

Contacts

Public ContactTomita Shimpei

New drug research center, Inc. Clinical Research Dept.

s-tomita@ndrcenter.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026